Thursday, 8 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Nephrocare Health Services Ltd

NSE: NEPHROPLUS · BSE: 544647 · Healthcare · 44 announcements

Share price
₹641.60
Market cap
₹6,438 Cr
Revenue (annual)
₹998.8 Cr
Net profit (annual)
₹76.84 Cr
P/E (TTM)
75.6×Sector 53.1×
Promoter holding
63.85%+0.00% QoQ
FII holding
8.78%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

16:19 IST BSE
Merger & Restructuring

Nephrocare Health Services Merger & Restructuring

Nephrocare Health Services Ltd announced the rationalisation and consolidation of its step-down subsidiaries in the Philippines. This internal reorganization streamlines the group's existing structure.

15:56 IST BSE
Merger & Restructuring

Nephrocare Health Services Merger & Restructuring Worth ₹10.25 Cr

Nephrocare's Philippines subsidiary acquired a dialysis center from Renal One Dialysis Corp for ≈₹10.25 Cr. The asset transfer expands the company's dialysis network.

Value
₹10.25 Cr
dialysis center acquired
1 dialysis centers
13:58 IST NSE
Merger & Restructuring

Nephrocare Health Services Merger & Restructuring Worth ₹10.88 Cr

Nephrocare Health Services' Philippines subsidiary acquired a dialysis center's assets for PhP 75 million. The transaction strengthens the company's international footprint in the healthcare sector.

Value
₹10.88 Cr
13:58 IST BSE
Merger & Restructuring

Nephrocare Health Services Merger & Restructuring Worth ₹11.25 Cr

Nephrocare Health Services' subsidiary entered an agreement to acquire a dialysis center in Philippines from Assumption Dialysis Center. The transaction is valued at PhP 75,000,000.

Value
₹11.25 Cr
13:48 IST BSE
Merger & Restructuring

Nephrocare Health Services Merger & Restructuring Worth ₹13.5 Cr

Nephrocare Health Services' subsidiary acquired dialysis center assets from Assumption Dialysis Center in the Philippines. The transaction is valued at PhP 75 million (approximately ₹13.50 Crore).

Value
₹13.50 Cr
17:59 IST NSE
Merger & Restructuring

Nephrocare Health Services Merger & Restructuring Worth ₹10.41 Cr

Nephrocare Health Services' overseas step-down subsidiary signed an Asset Transfer Agreement to acquire assets of Juan Nephro Dialysis Center for PhP 71.8 million.

Value
₹10.41 Cr
11:18 IST NSE
Merger & Restructuring

Nephrocare Health Services Merger & Restructuring

Nephrocare Health Services entered an Asset Transfer Agreement to acquire a dialysis center in Philippines. The acquisition is valued at PHP 71,800,000.

12:49 IST BSE
Merger & Restructuring

Nephrocare Health Services Merger & Restructuring Worth ₹5.69 Cr

Nephrocare Health Services' subsidiary NPKSC will acquire a 51% stake in NHSSAC for ₹5.69 Crore. This internal restructuring aims to optimize the Group's Saudi Arabia operations.

Value
₹5.69 Cr
14:36 IST NSE
Merger & Restructuring

Nephrocare Health Services Merger & Restructuring

Nephrocare's Philippines subsidiary signed a PhP 151.6 million asset transfer to acquire a dialysis centre. The deal adds a healthcare asset to the Group’s portfolio.

16:18 IST NSE
Merger & Restructuring

Nephrocare Health Services Merger & Restructuring Worth ₹0.1 Cr

Nephrocare Health Services incorporated a new wholly-owned step-down subsidiary in Kazakhstan. This ₹0.10 Crore investment supports the international expansion of its dialysis service network.

Value
₹0.10 Cr
22:19 IST NSE
Merger & Restructuring

Nephrocare Health Services Merger & Restructuring Worth ₹0.5 Cr

Nephrocare Health Services incorporated a new wholly-owned step-down subsidiary, NPHSK LLP, in Kazakhstan. The entity will expand kidney care and dialysis services into the region.

Value
₹0.50 Cr